efficacy of sacituzumab govitecan by trop-2 expression in patients with muc
Published 2 years ago • 288 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
2:57
efficacy of sacituzumab govitecan in muc by trop-2 expression
-
4:04
efficacy of sacituzumab govitecan by trop-2 expression in metastatic urothelial carcinoma
-
1:49
final os analysis of sacituzumab govitecan in tropics-02
-
1:34
sacituzumab govitecan effective for hr metastatic breast cancer regardless of trop-2 status
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
6:17
antibody-drug conjugates in tnbc: sacituzumab govitecan
-
42:03
b7-h3 antibody-drug conjugates | oncology today with dr neil love: the emerging role of...
-
3:44
correlation of trop-2 expression with clinicopathological characteristics and outcome in tnbc
-
1:01
sacituzumab govitecan and other adcs in prostate cancer
-
5:07
tropics-02: sacituzumab govetican improves pfs versus physicians choice for hr /her2- mbc
-
1:00
tropics-02: sacituzumab govitecan in hr /her- breast cancer
-
2:58
#esmo22 highlights on sacituzumab govitecan in hr /her2- metastatic breast cancer: tropics-02
-
4:38
2nd interim analysis of os from tropics-02: sg in hr /her2- breast cancer
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
4:42
tropics-02 shows sacituzumab govitecan os benefit in hr , her2– advanced breast cancer | hope rugo
-
2:38
trophy-u-01 cohort 3: sacituzumab govitecan pembrolizumab for patients with muc
-
3:59
sacituzumab govitecan increases pfs for hr /her2- metastatic breast cancer
-
2:15
ascent: sacituzumab govitecan biomarker analysis
-
7:26
sacituzumab govitecan increases pfs for hr /her2‐ advanced breast cancer patients
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
1:55
tropics-03: sacituzumab govitecan as a 2l treatment for es-sclc